Oppenheimer Reviews Affymetrix 1Q Results

In a recent report by Oppenheimer, it gave a quarterly update for Affymetrix Inc. AFFX following the release of AFFX's 1Q earnings. According to Oppenheimer, Affymetrix experienced negative revenue growth but were close to forecast expectations. Oppenheimer explains, “1Q11 revenue of $73.7M (-8% y/y) was in line with or expectations but behind the Street estimate of $74.5M.” On a positive note, “The bottom line was aided substantially by product gross margin that was 540bp better than our estimate”, says Oppenheimer. Affymetrix currently has a Perform rating and closed yesterday at $5.83.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorAnalyst RatingsaffymetrixHealth CareLife Sciences Tools & ServicesOppenheimer
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!